Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Minoxidil solution helps hair regrowth in alopecia areata, with 5% being more effective.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Baricitinib is effective and safe for treating severe alopecia areata.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

Minoxidil helps hair regrowth in alopecia areata safely.

3% topical minoxidil effectively treats extensive alopecia areata with few side effects.

Higher minoxidil concentration (5%) works better for severe hair loss, with most patients seeing regrowth in 48-60 weeks.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Stem cell therapy may help treat tough hair loss cases.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.